Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children
ContributorsRudin, Christoph; Burri, Marcus; Shen, Yang; Rode, Richard; Nadal, David; Pediatric infectious disease group of Switzerland
CollaboratorsGervaix, Alain; Myers, Catherine Jayne; Posfay Barbe, Klara; Siegrist, Claire-Anne
Published inThe Pediatric infectious disease journal, vol. 27, no. 5, p. 431-437
Publication date2008
Abstract
Keywords
- Adolescent
- CD4 Lymphocyte Count
- Child
- Child, Preschool
- Cohort Studies
- Female
- HIV Infections/drug therapy/immunology/virology
- HIV Protease Inhibitors/adverse effects/therapeutic use
- HIV-1
- Humans
- Infant
- Infant, Newborn
- Longitudinal Studies
- Male
- Nelfinavir/adverse effects/therapeutic use
- Pregnancy
- Pyrimidinones/adverse effects/therapeutic use
- Ritonavir/adverse effects/therapeutic use
- Switzerland
- Treatment Outcome
- Viral Load
- Withholding Treatment
Citation (ISO format)
RUDIN, Christoph et al. Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children. In: The Pediatric infectious disease journal, 2008, vol. 27, n° 5, p. 431–437. doi: 10.1097/INF.0b013e3181646d5a
Main files (1)
Article (Accepted version)
![accessLevelRestricted](assets/images/access-level-restricted.png)
Identifiers
- PID : unige:2145
- DOI : 10.1097/INF.0b013e3181646d5a
- PMID : 18382386
ISSN of the journal0891-3668